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Abstract
Various studies have demonstrated that alterations in the deformability of cancerous cells are strongly linked to the actin
cytoskeleton. By using atomic force microscopy (AFM), it is possible to determine such changes in a quantitative way in order to
distinguish cancerous from non-malignant cells. In the work presented here, the elastic properties of human bladder cells were
determined by means of AFM. The measurements show that non-malignant bladder HCV29 cells are stiffer (higher Young’s
modulus) than cancerous cells (HTB-9, HT1376, and T24 cell lines). However, independently of the histological grade of the
studied bladder cancer cells, all cancerous cells possess a similar level of the deformability of about a few kilopascals, significantly
lower than non-malignant cells. This underlines the diagnostic character of stiffness that can be used as a biomarker of bladder
cancer. Similar stiffness levels, observed for cancerous cells, cannot be fully explained by the organization of the actin cytoskeleton
since it is different in all malignant cells. Our results underline that it is neither the spatial organization of the actin filaments nor the
presence of stress fibers, but the overall density and their 3D-organization in a probing volume play the dominant role in control-
ling the elastic response of the cancerous cell to an external force.
Introduction
During oncogenic progression, many cancer-related alterations
change both the internal structures of cells and also their
surroundings, i.e., the extracellular matrix (ECM). During last
two decades, much research has been carried out that demon-
strated a larger deformability of living cancerous cells, which is
in contradiction to the macroscopically detected stiffening of
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various tumors. Several papers demonstrated the possible influ-
ence of the ECM surrounding cancerous cells in the tumor
progression [1,2]. The best example is breast cancer, whose
solid tumors are detectable in macroscale by palpation whereas
single cells show a larger deformability [3]. In this context, it
has also been proposed that tumorigenesis in breast tissues is
driven by changes in the mechanical properties of the extracel-
lular matrix [2,4]. Remarkably, in this case the ECM of the
malignant cells is stiffer (reflected by a higher Young’s
modulus) as compared to the ECM of non-malignant tissues [2].
Those studies underline the connection between changes in the
mechanical properties of the cell and the extracellular matrix,
and the presence or development of progressive diseases.
However, the specific role of the mechanical properties of the
cells and the extracellular matrix in pathogenesis such as tumor
progression remain poorly understood at best. The relationship
between mechanics at the cellular level and tumorigenesis
represents a new perspective for which many issues need to be
addressed.
The studies of cell mechanics have gained great importance
with the advent of AFM measurements, which demonstrated the
capability to probe single cells and underlining a correlation
between cell mechanics, in particular elasticity, and cancer
[5,6]. The first measurements showed that cancerous human
bladder cells were softer than non-malignant bladder cells.
Further measurements of cancerous cells have confirmed that a
lowering of the elastic modulus of the cells is a general feature
of cancer transformation [6-12]. This change is probably asso-
ciated with the enhanced capability to migrate and to adapt to
changing environments, which is observed in metastasis. Impor-
tantly, these results are valid for other cell lines, such as ovary
or prostate cancers [10], and can be extended also to primary
cells [6,13] and tissue sections [5,12] that were collected from
human patients. For example, a comparison of the elastic prop-
erties of normal and benign breast tissues gives a wide distribu-
tion of the Young’s modulus, in which a peak at lower
values characterizes malignant tissues. It has also been found
that the Young’s modulus distribution in cancerous cells
is narrower than the distribution found in non-malignant
cells [4,6]. However, the elements of the cell that contributes to
its mechanical response as measured by the AFM need to be
clarified.
AFM studies on cells are often combined with the use of drugs
that modify the mechanical response of the cell [14,15]. The
influence of the different elements of the cytoskeleton on the
force response can be monitored by selectively inhibiting the
formation of some of them [16-19]. By disaggregation of actin
filaments with the use of different types of cytochalasin, Rotsch
and Radmacher have reported a decrease of the Young’s
modulus of fibroblasts [16]. Similar findings regarding the role
of actin filaments have been reported in other types of cells
such as lymphocyte and Jurkat cells [19]. The role of the micro-
tubules (MT) in AFM measurements remains open. Pelling et
al. performed immunofluorescence and AFM studies in order to
determine the influence of the MT on the cell membrane in
response to serum conditions and nocodazole [17]. Their results
show that the stiffness depends on the interplay between
dynamically different types of MT configurations (unstable and
stable) and intermediate filaments (IF), which all act to impart a
distinct cellular type of transient metastability. On the other
hand, it has been reported that the disassembly of the MT of
fibroblasts by using colchicine and colcemide does not lead to a
softening of the cell [16]. The abovementioned research shows
that disruption of cytoskeletal filaments is useful for assesing
the link between the elastic properties of cells and the structure
of the cytoskeleton. It is also worth mentioning that such an ap-
proach can be used for studying the influence of certain such
compounds as chitosan [14] or cisplatin [20] on the mechanics
of single cells, while pointing out that studies on the correlation
between the mechanical properties and the structure of the actin
cytoskeleton are particularly important for developing and
monitoring cancer therapies.
It is well established that actin filaments are mostly responsible
for the mechanical properties of cells that are measured by the
AFM. Therefore, there have been several attempts trying to
show the correlation between the 2D-organization of actin fila-
ments and cells stiffness in relation to cancer invasion. The rela-
tion between the stiffness of cancer cells and the 2D-organiza-
tion of the actin cytoskeleton has been reported for breast [3],
thyroid [11] and ovarian [21] cancers. For stiffer cells, the actin
filaments distribution usually revealed two types of filament
organization, i.e., an actin cortex and well-formed linear actin
bundles (i.e., stress fibers) that span over a whole cell. For
softer cells, the actin filaments were less organized. Mostly,
short filaments were observed. If F-actin bundles were present,
they were shorter and randomly oriented. In particular for
ovarian cancer, the correlation between the migratory behavior
of cells and their stiffness has been demonstrated [21]. In other
studies, the larger deformability of the mouse ovarian cells has
been correlated with the dysregulation of actin (stress) fibers,
which influences both fiber thickness and organization, as
shown by confocal microscopy of early and late stages of
ovarian cancer progression [22].
Here, we study the correlation between the elastic properties
and the expression and organization of the actin cytoskeleton in
human bladder cancer cells. We have chosen four cell lines with
various histological grades. Those lines differ in terms of the
organization of the cytoskeleton (presence/absence of stress
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Figure 1: (A) Scheme of experimental setup. (1) V-shaped cantilever-tip ensemble; (2) cell membrane; (3) cell nucleus; (4) actin filaments; (5) inter-
mediate filaments; (6) microtubules; (7) cover slip; (8) optical microscope lens. (B) Optical image of the cantilever positioned on top of the cell treated
with cytochalasin D. After being treated with cytochalasin D, the cells shrink to a circular form.
fibers, distinct actin expression level) and the elastic properties
measured by force spectroscopy. The cancerous cells are more
compliant with respect to the non-malignant cells. Regardless of
histological grades, the deformability of the cancerous cells
reaches a similar level but the organization of actin filaments
remains dependent on the cell type. These data underlines the
complexity of the remodeling process in actin filaments in
cancers that is expressed in the elastic properties of cells. Our
findings show that in human bladder cancer cells, both the
expression level of actin (in particular, β-actin) and its 3D-orga-
nization in the probing volume govern the elastic properties.
The organization of actin filaments present on the surface of a
cell as probed by AFM and fluorescence microscopy is not
sufficient to fully explain the cellular stiffness. Additionally, the
presence of actin fibers (stress fibers) is not a prerequisite for a
deformability of cancer bladder cells. Moreover, the observed
sudden drop of stiffness is a clear indication of cancer-related
changes in human bladder cells, which strongly supports the
usefulness of cell deformability in detecting cancer-related
changes in bladder cancer. Such a relation has not been
observed so far for any other cells measured by AFM in which
usually a gradual drop of stiffness was observed.
Results
Cell morphology
Force spectroscopy experiments were performed on living cells,
which were located on an inverted optical microscope
(Figure 1). The optical microscope was also used to estimate the
position of the AFM probe (tip) along the cell. Once a position
was selected (close to the cell nuclei), the tip was approached
towards the cell surface until a repulsive force reached the set
point value of 100 pN.
The AFM images were taken over an area of 20 × 20 μm2 with
512 pixels per line. The scan rate was varied from 0.5 to 1.0 Hz
depending on the cell type. Figure 2 shows the AFM topog-
raphy, error signal, single cross-sections and the fluorescence
images of the cell lines studied here, non-malignant HCV29 and
the malignant cells HTB-9, HT-1376, and T24, respectively.
The AFM error image (panels A, E, I, and M) enables to visu-
alize the cell cytoskeleton that lies beneath the cell membrane.
The filaments observed by AFM correspond to the actin fila-
ments. Although, they are dispersed throughout the whole cell,
they are mainly concentrated close to the cell membrane to form
the so called actin-cortex. The AFM error image shows that
these filaments are organized in two groups: (i) short actin fila-
ments and (ii) and bundles of long acting filaments (stress
fibers). The presence of these two groups in the AFM image
depends on the cell type. In the non-malignant HCV29 cells
both short actin filaments and stress fibers are visible. Similarly,
both structures are present in cancerous T24 cells (transitional
cell carcinoma). However, the other types of malignant cells,
HTB-9 (grade II, carcinoma) and HT-1376 (grade III, carci-
noma) do not show the presence of stress fibers. These results
are consistent with fluorescence microscopy images of actin
filaments stained by using phalloidin that was labeled with
Alexa Fluor 488 dye (Figure 2, panels D, H, L, P and Figure S1
in Supporting Information File 1). Similarly to the AFM images
the stress fibers are only visible in the non-malignant HCV29
cells and the cancerous T24 cells.
The cross-sections along the marked lines on the AFM topog-
raphy (Figure 2, panels C, G, K, and O) show the apparent
height differences between two positions along the cell surface.
One located above the nucleus and the other close to the cell
edge. The height ranges from 3 to 4 μm depending on the cell
type. The highest values were observed for HTB-9 cells
(≈4 μm). The others cell types had similar height of about 3 μm.
We note that the size of the nucleus does not seem to correlate
with the observed height. For example, the HTB-9 cell has the
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Figure 2: Force and fluorescence microscopy images of bladder cells. (A–D) Non-malignant cells, HCV29; (E–H), HTB-9 cells, grade 2; (I–L)
HT-1376 cells, grade 3; (M–P) T24, grades 3 and 4. The AFM measurements were performed on regions centered over the cell nucleus marked with
an arrow in the fluorescence images. The 1st column (panels A, E, I and M panels) is the AFM error signal. The 2nd column (B, F, J and N) shows the
topography (AFM). The 3rd column (C, G, K and O) shows the apparent height profile. The 4th column (D, H, L and P) shows the fluorescence
microscopy images. The arrows indicate the cells where the AFM images were recorded (blue: cell nucleus; green: actin cytoskeleton).
smallest nucleus; however, it has the largest height as measured
from the substrate baseline.
Expression of actin
Actin is a globular protein that forms microfilaments. It exists
in α, β, and γ isoforms. The α-actin was found in muscle tissues,
the β- and γ-actins coexist in most cell types as components of
the cytoskeleton [23-25]. Moreover, the transition from the
epithelial to the mesenchymal phenotype reported for
cancer progression requires a remodeling of the actin
cytoskeleton [26]. This phenomenon is visible in the fluores-
cence and AFM images obtained for the four studied human
bladder cell lines.
In order to verify whether changes in the organization of
the actin filaments are accompanied with the different expres-
sions of actin, we have used the Western blot (Figure 3). The
analysis was performed for the same number of cells (i.e.,
2.56 × 106 cells/mL) for each studied cell line. This analysis
exhibited two bands at 42 and 43 kDa. The used antibody
targets all the known actin isoforms with a molecular mass of
42 kDa in globular and fibrous forms. The band of 43 kDa
probably corresponds to cytoplasmic actin isomers of 43 kDa
that possess similar epitopes as those of 42 kDa.
The obtained results showed the higher amount of actin in non-
malignant HCV29 cells and the lowest in cancerous HT-1376
Beilstein J. Nanotechnol. 2014, 5, 447–457.
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Figure 4: (A) Exemplary force curve recorded on a HT-1376 cell (blue dots). The red solid line represents a curve taken on a hard glass surface (cali-
bration curve). The indentation δ is the horizontal difference between these curves (see Equation 2). The contact point is chosen as the origin.
(B) Force-versus-indentation curve (blue dots) fitted with Sneddon’s equation for a conical tip (red line).
Figure 3: Total expression of actin in human bladder cells. The used
antibody targets all known actin isoforms with a molecular mass of
42 kDa (globular actin and fibrous actin). The upper band (43 kDa)
probably corresponds to cytoplasmic actin isomers with 43 kDa that
possess the similar epitopes as those of 42 kDa.
(grade III, carcinoma) and T24 (transitional cell carcinoma)
cells. To quantify the expression, the ImageJ program was used
to determine the area under each band. The largest area corre-
sponds to the HCV29 cells. The band area of the cancerous cells
with respect to HCV29 was 73%, 35% and 42% for the HTB-9,
HT-1376 and T24 cell lines, respectively. The results show that
when cells with increasing tumor grading are measured, the
amount of actin decreases in the cancerous cells as compared to
non-malignant ones.
Determination of the Young’s modulus
The elastic properties of the cells were determined by using
Sneddon’s model for a conical shape of the tip [27]. First, the
force curves were converted into force-versus-indentation
curves and those curve were fitted to Equation 1 (see section
Experimental: Force spectroscopy on living cells). Because the
Young’s modulus of the tip is about 160 GPa (seven orders of
magnitude larger than that of the cells), we can assume that
Young’s modulus of the interface is Eeff ≈ Ecell/(1 – ν2).
Figure 4A shows a typical force curve obtained on a HT-1376
bladder cell together with a force curve obtained on a stiff
surface (glass). For a given deflection (or force), the difference
between the piezo displacement for the stiff and compliant
surface gives the indentation (Equation 2, see section Experi-
mental: Force spectroscopy on living cells). Figure 4B shows
the force-versus-indentation curve derived from Figure 4A and
the fit obtained with the Sneddon’s model assuming a conical
AFM tip with half-angle of 20°. The Young’s modulus obtained
from the fit was 6.1 kPa. The force spectroscopy data has been
acquired in the region of the cell above the nucleus. The experi-
mental force curves show some deviations from a parabola.
Consequently, the parameters of the fitting will depend on the
fitting length (indentation). For that reason, any conclusion
derived from the data has to be verified for all the indentation
depths studied here. On the other hand, the relative error in the
determination of the contact point will decrease for larger
indentations.
The results obtained for all recorded cell lines yielded the
corresponding distributions of the Young’s moduli. Figure 5
shows the Young’s modulus values collected from the four
bladder cell lines of this study and calculated for the indenta-
tion from 0 to 300 nm. Depending on the cell type distinct
features are observed in the histograms. For the non-malignant
cells (panel A), the observed distribution can be decomposed in
two Gaussians, the larger one centered at 16.0 ± 0.9 kPa and the
smaller centered at 33.0 ± 2.0 kPa. For HTB-9 (panel B) cells
most of the data is centered at 3.0 ± 0.1 kPa with a small tail
centered at 6.4 ± 0.5 kPa; for T24 (panel D) cells the dominant
peak is centered at 2.9 ± 0.5 kPa while the secondary contribu-
tion has its maximum at 6.2 ± 0.6 kPa. The histogram for
HT-1376 (panel C) cells shows a single maximum centered at
5.2 ± 0.1 kPa. We also observe that the histograms are narrower
for all cancerous cells. This is in agreement with previous
Beilstein J. Nanotechnol. 2014, 5, 447–457.
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Figure 6: (A) Elasticity of living bladder cells as a function of the indentation depth. The data is presented as mean ± SD. (B) Comparison of the elas-
ticity of the cells before and after treatment with cytochalasin D (Cyt-D). The data is presented as mean ± SD.
results that showed that the distribution of the Young’s modulus
becomes narrower for metastatic cells [4,14].
Figure 5: Distribution of Young’s moduli determined by fitting the
curves within the indentation range up to 300 nm. The elasticity
histogram is broader for the non-malignant cells (HCV29) than for the
HTB-9 and the T24 cancerous cells. Histogram bin width of 500 Pa.
Figure S2 (Supporting Information File 1) shows the Young’s
moduli of the same cell lines, but in this case the fitting has
been extended up to an indentation depth of δ = 500 nm. Two
main conclusions are derived with respect to the data obtained
at δ = 300 nm. First, the maxima of the distributions are shifted
to lower values. Second, the distribution width is smaller. Those
results apply for all bladder cell lines of this study.
Depth-dependent changes of the Young’s
modulus
Figure 6A presents the changes of the Young’s modulus as a
function of the indentation depth between 100 and 500 nm. For
the non-malignant HCV29 cells the modulus goes from 50 kPa
at 100 nm to 10 kPa at 500 nm. For the malignant cells the
Young’s modulus decreases from about 15 kPa at 100 nm to
5 kPa at 500 nm. The decrease of the Young’s modulus with δ
has been previously reported [18] although this effect is still not
fully understood [5,18,19].
Effect of cytochalasin D on the elasticity of
the cells
In order to verify the influence of the actin filaments and their
structure on Ecell, some of the cell lines were treated with
cytochalasin D (Cyt-D), which is known to depolymerize the
actin filaments. This results in a reduction of the Young’s
modulus [16]. However, Cyt-D does not affect the structure of
MT or IF. Figure S3 (Supporting Information File 1) shows the
Young’s moduli of the HCV29 cell line before and after expo-
sure to Cyt-D measured at δ = 300 nm. The actin cytoskeleton
of HCV29 cells is composed of short actin filaments and stress
fibers. The stress fibers are visible in Figure 2 and Figure S1
(Supporting Information File 1) for the cell lines HCV29 and
T24. After adding Cyt-D, the modulus drops from 21 to 2 kPa.
We note that the differences between treated and non-treated
cells are preserved across the different individual cells and cell
locations. The Young’s moduli measured on different cells of
the same cell line are similar (Figure S3, Supporting Informa-
tion File 1). In fact the variability observed for each cell type
could be attributed to local changes in the region around the cell
where the measurement has been performed. The measurement
in each of the panels of Supplementary Figure S3 has taken
over 4 h.
The actin cytoskeleton structure of HTB-9 cells is mainly
composed of short actin filaments. In these cells, there are virtu-
ally no stress fibers to be seen. In this cell line a treatment with
Beilstein J. Nanotechnol. 2014, 5, 447–457.
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Cyt-D causes a decrease of Ecell from 15 kPa to 5 kPa
(δ = 100 nm) and from 6 kPa to 2 kPa (δ = 300 nm). Figure 6B
shows the change of the Young’s moduli for HCV29 and
HTB-9 cells before and after exposure to Cyt-D for different
indentations. Interestingly, the elastic response of non-malig-
nant and malignant cells is almost identical after exposure to
Cyt-D.
Statistical significance of the cells Young’s
modulus
The statistical significance of the Young’s modulus measure-
ments for the different cell lines was verified by applying the
Tukey–Kramer method [28]. Here the test was performed at a
significance level of P = 0.05 (Table 1). The test shows statisti-
cally significant differences between the Young’s modulus
values of HCV29 non-malignant cells and those obtained on
cancerous cells. Similarly, relevant statistical differences are
found between the values measured before and after the treat-
ment with cytochalasin D. It also shows that among cancerous
cells (HTB-9, HT-1376 and T24) there are no statistical differ-
ences in their values, at least for indentation depths between
200 and 400 nm. It is worth to mention that cells treated with
Cyt-D had similar Young’s moduli for both cell lines (HCV29
and HTB-9).
Table 1: Tukey–Kramer multiple comparison test of the results shown
in Figure 6 with significance level P = 0.05 for all indentation depths.a
cell type HTB-9 HT-1376 T24 HCV29
+ Cyt-D
HTB-9
+ Cyt-D
HCV29 *** *** *** *** ***
HTB-9 ns nsb *** ***
HT-1376 nsb *** ***
T24 *** ***
HCV29 +
Cyt-D
ns
a*** P < 0.001; ns: no significant differences between samples; bThere
are two exceptions for the data represented: for HTB-9–T24 at 100 nm
P < 0.01 and for HT-1376–T24 at 500 nm P < 0.05.
Discussion
The integration of force and fluorescence microscopies enables
one to obtain comprehensive information about the morphology
of the cells. The latter provides the information about fluores-
cently labeled structures while AFM delivers the topology and
the mechanical properties of the sample. In our studies, the fluo-
rescent images of actin filaments were compared with the
surface topography. The cytoskeleton is important for a normal
cell function, however, cancer progression changes its role by
using it as a tool to alter cell growth, stiffness, movement and
invasiveness [26]. The actin cytoskeleton serves as a scaffold
for signaling, as a connection to the extracellular environment,
and as a mechanosensor. However, there is no general evidence
that changes in the expression or organization of actin promotes
or inhibits cancer metastasis. It seems that cancerous cells reor-
ganize the actin cytoskeleton to alter the growth or adhesion or
the mechanical properties to enhance their survival rate during
various phases of tumor progression and metastatic spreading.
This reorganization process involves both re-arrangements of
actin filaments in the cell and also changes in the actin expres-
sion [27]. Our results on human bladder cancer cells showed
that the level of actin (a component of the cell cytoskeleton and
also a mediator of internal cell motility) in non-malignant
HCV29 cells is the highest. Its drops as follows: HTB-9
(grade II, carcinoma) > T24 (transitional cell carcinoma) >
HT-1376 (grade III, carcinoma) cells. Moreover, in non-
muscles cells, the actin cytoskeleton in cells can be divided into
two groups: short actin filaments forming a cortex and long
stress fibers that consist of bundles of single actin filaments.
The actin cortex is located beneath the cell membrane while the
actin stress fibers span over the whole cell. The results obtained
on human bladder cells (non-malignant HCV29 and three
cancerous lines HTB-9, HT-1376 and T24) showed various
organizations of the actin cytoskeleton as observed by fluores-
cence microscopy. In non-malignant HCV29 cells, both short
actin filaments and stress fibers are visible. Similarly, both
structures are present in cancerous T24 cells (transitional cell
carcinoma). The two other cancerous cells, HTB-9 cells
(grade II, carcinoma) and HT-1376 (grade III, carcinoma) only
show the presence of short actin filaments. In recent decades, a
novel functionality of the AFM, i.e., stiffness tomography,
has been demonstrated [29,30] for neurons to deliver a 3D
recording of the Young’s modulus. The results have shown the
presence of hard structures, which are attributed to cortical actin
cytoskeleton. However, the organization and mechanical prop-
erties of single actin filaments stress fibers have not been shown
by this technique. Nevertheless, the imaging of the cell surface
by using AFM in contact mode can convey information about
the superficial layers of the actin cytoskeleton. In our case the
topography of each studied cell lines correlates with the images
of phalloidin stained actin filaments, which were recorded by
using fluorescence microscopy.
The actin cytoskeleton has been reported to play the main role
in the mechanical properties of living cells [15,31]. The
observed increase of cellular deformability, which is induced by
cytochalasin D, relates to the mechanical properties of the
cytoskeleton with the actin network lying beneath the cell
membrane. However, it cannot be specified, which form of
spatial organization of actin filaments dominates. The highest
expression of actin and the most abundant presence of stress
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fibers, which is observed in HCV29 cells, were accompanied by
a large value of the Young’s modulus. It is clearly visible that a
lower expression of actin, which is observed in malignant cells
(HTB-9, HT-1376 and T24), is associated with a lower Young’s
modulus. All malignant cells showed similar values of the
Young’s modulus. However, the elastic properties of the
cancerous cells seem to be independent of the presence/absence
of stress fibers. The stress fibers are present in T24 cancerous
cells (transitional cell carcinoma) but not in HTB-9 (grade II,
carcinoma) and the HT-1376 (grade III, carcinoma).
The altered elastic properties of single cells is nowadays almost
believed to be a general feature of cancer progression, which
has been already shown in various measurements performed by
using atomic force microscopy. The examples encompass
human bladder [5,32], breast [3], colon [31], prostate [10,32],
thyroid [11] and cervical cells [33]. A similar relationship was
obtained in previous studies for human bladder cancer cells [5].
The non-malignant HCV29 cells were significantly stiffer than
the cancerous ones. It should be also pointed out that these
measurements are in agreement with the data reported earlier, in
which the stiffness of both HCV29 and T24 cells was measured
by force spectroscopy [5,14]. This observation is particularly
important since these cells were grown previously on a glass
coverslip covered with poly-L-lysine. In the present studies no
glass surface modification was introduced. Thus, substrate
chemical properties do not change the relationship between
non-malignant HCV29 and cancerous T24 cells. The compari-
son performed in the previous studies showed that two non-
malignant cell lines (HCV29 and Hu609) were significantly
stiffer than three cancerous ones, i.e., Hu456 (grade I, carci-
noma), T24 (transitional cell carcinoma), BC3726 (HCV29
cells transformed with ν-ras oncogene). However, in the studies
from 1999 [5], there was no fluorescence microscopy involved
to show the organization of actin filaments in the studied cell
lines. In our work we have observed the same relation. Indepen-
dently of the histological grade, the cancerous cells are more
deformable. This point out the usefulness of the AFM to detect
bladder cancer cells –regardless of the state of cancer progres-
sion– soft cells indicate a malignant phenotype.
The fluorescent images of the actin filaments, obtained in the
present study, showed surprisingly that the 2D-organization of
these filaments on the cell surface is not solely responsible for
the observed stiffness of all malignant cells. It seems that in our
case, the elastic properties are governed by both the expression
level of F-actin and its 3D-organization in the probing volume.
The dependence of the Young’s modulus on the indentation
depth represents another important element of the presented
data. In the range studied here between 100 and 500 nm, the
Young’s modulus decreases with the indentation depth
(Figure 6A). The decrease of the Young’s modulus with the
indentation depth indicates little influence of the solid support
on the measurements [34]. Here we are focused on the ability to
distinguish cells of different malignancy degrees. Consequently,
in order to visualize the variations across the different cells lines
we have normalized the Young’s modulus of the different cells
to the one obtained at the same indentation for the non-malig-
nant cells. Two main observations are obtained from the
normalized plot. First, non-malignant bladder cells are stiffer
than malignant cells. Second, for the cell lines studied here, the
histologically determined tumor grade does not seem to be
reflected in the elastic properties of the cells.
The treatment of cells with cytochalasin D resulted in a marked
decrease of their Young’s modulus (Figure 6B). The Cyt-D
inhibits the actin polymerization by binding to the fast growing
plus ends of the microfilaments and blocking both the assembly
and the disassembly of individual actin monomers from the
bound end. It has been reported that the results of its action is a
drop of the overall cell elasticity [16,33]. The correlation
between the reduction of the Young’s modulus and the depoly-
merization of the actin filaments supports a predominant role of
these filaments on the stiffness of the cells. In order to verify
how the organization of the actin cytoskeleton influences the
mechanical properties, HCV29 and HTB-9 cells were treated
with 5 μM Cyt-D. The observed decrease of the elastic
modulus confirms the pre-dominant influence of actin fila-
ments on the elastic properties. The results was independent of
both the 2D organization of actin filaments and on the expres-
sion level of actin (similar values were obtained 1.8 ± 0.1 kPa
and 1.7 ± 0.1 kPa for HCV29 and HTB-9, respectively). The
deformability of all studied cancerous cells is slightly larger
than that of the cell treated with cytochalasin D. This points out
to partial but extensive changes in actin cytoskeleton structure
induced by cancer progression.
The relation between the cell deformability and the degree of
invasiveness has attracted attention almost from the beginning
of the elasticity measurements of cancerous cells. The compari-
son between various cell lines of the same origin like breast,
prostate, bladder, thyroid, and ovarian cancers, only shows such
a relation for ovarian cancers [21]. In the other research either
only a comparison between only two cell lines has been done or
such correlation could not be shown clearly. In our case, for
bladder cancer, the first results from 1999 showed a significant
difference between non-malignant and cancerous cells without
any consideration of their degree of invasiveness. The results
presented here, now clearly demonstrate that most probably, in
human bladder cancers, cells acquiring a more invasive pheno-
type become more deformable at early stages of cancer progres-
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sion. This makes the cell stiffness a powerful biomarker for
detecting cancer-related alterations in human bladder tumors.
Conclusion
Nanomechanical measurements performed with a force micro-
scope at the single cell level have been applied to characterize
the elastic properties of human bladder cancer cells. All malig-
nant bladder cells have Young’s moduli about 2–3 times lower
that those non-malignant cells. The low Young’s modulus
(higher cellular deformability) seems to occur at an earlier stage
of cancer progression and it does not seem to evolve with the
metastatic phenotype. It correlates with a partial lack and/or
depolymerization of the actin filaments. The data implies that
the elastic response is dominated by the expression of F-actin.
However, the presence of actin stress fibers (observed in non-
malignant HCV29 and cancerous T24 cells) is not a prerequi-
site for a smaller cellular deformability of cancer bladder cells.
The stress fibers observed in T24 cells produce a rather small
increase of the Young’s modulus. This strongly suggests that
the deformability of cancer cells is mainly related to the
3D-organization of actin filaments (both short filaments, and
stress fibers) together with their density. The elastic properties
of cancerous cells (HTB-9, HT-1376 and T24) were inde-
pendent of the cell line, the stage of cancer progression, and the
cell cycle. Therefore, they underline the usefulness of atomic
force microscopy to detect bladder cancer cells because regard-
less on the state of cancer progression, softer cells indicate a
malignant phenotype.
Experimental
Cell lines: Four bladder cell lines with epithelial origin have
been studied: non-malignant transitional epithelial cells of the
ureter (HCV29, Institute of Experimental Therapy, Wroclaw,
Poland), which serve as a reference; urinary bladder cell carci-
noma (HTB-9, grade II, ATCC, LGC Standards); urinary
bladder cell carcinoma (HT-1376, grade III, ATCC, LGC Stan-
dards) and transitional cell carcinoma (T24, ATCC, LGC Stan-
dards).
The HCV29 and the T24 cells were grown in RPMI-1640
medium (Sigma) supplemented with 10% Fetal Bovine Serum
(FBS, Sigma). The HTB-9 cells were grown in RPMI-1640
supplemented with 10% FBS, 1% HEPES (4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid, Sigma) and 1% sodium pyru-
vate (Sigma). Finally, the HT-1376 cells were grown in Eagle’s
medium (EMEM, LGC Standards) supplemented with 10%
FBS (LGC Standards). The cells were cultured on glass cover-
slips placed inside plastic Petri dishes at 37 °C in a 95% air/
5% CO2 atmosphere. The relative humidity was kept above
98%. The cells were measured 3 to 4 days after seeding. The
cells treated with cytochalasin D (Sigma) were first rinsed with
RPMI-1640 medium and then they were immersed in a 5 µM
Cyt-D solution in RPMI-1640 medium for 1 h at 37 °C.
Actin expression in bladder cells: The expression of β-actin in
the studied human bladder cells was determined by using
Western blot analysis, performed in analogous way as in [35].
Briefly, for this analytical technique, which uses gel elec-
trophoresis to separate native proteins, the same number of cells
of about 2.56 × 106 cells per mL for each cell line was lysed
and loaded on 12% gels for SDS-PAGE and afterwards trans-
ferred to a polyvinylidene difluoride membrane (Roche). After
blocking with casein solution, the membranes were then incu-
bated overnight with the primary antibody against actin
(1:10000, 0.025 µg/mL, BD Biosciences).
Force spectroscopy of living cells: Force spectroscopy
measurements were performed by using a commercial AFM
(model XE120, Park Systems, South Korea). We used v-shaped
silicon nitride cantilevers terminated with a silicon tip
(MLCT-C, Bruker, USA). Those cantilevers are characterized
by a nominal spring constant k = 0.01 N/m while the length of
the tip length is about 3 µm long, with a half-angle of 20° and a
radius of 20 nm. The sensitivity of the photodiode was cali-
brated on a rigid glass surface.
Force-versus-distance curves (force curves hereafter) were
acquired in a 25-µm2 region centered above the nucleus of the
cell. The curves were acquired in 64 different positions sep-
arated by about 600 nm. The maximum indentation depth was
established by the value of the peak force; in this case, it was set
to 1 nN. The curves were acquired with a speed of 5 μm/s. The
force-versus-indentation curves were obtained by subtracting
the force curves recorded on a stiff glass surface from the ones
recorded on the cell surfaces. The elastic modulus (Young’s
modulus) was determined by fitting the force-indentation curve
(approach section) to the Sneddon’s model [27,36] while
assuming a conical tip. Then, the indentation depth and the
effective Young’s modulus Eeff are related by
(1)
where F is the loading force, θ is the half-angle of the cone, ν is
the Poisson coefficient of the cells (0.5 in this study), and δ is
the indentation depth. The indentation is determined from the
displacement zp of the piezo-scanner, the initial contact dis-
tance z0, and the deflection given by a hard wall F/k,
(2)
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All experiments were performed at room temperature in a
culture medium RPMI-1640 supplemented with 10 mM
HEPES. For the cells treated with Cyt-D the buffer was 5 μM
Cyt-D in RPMI-1640 medium.
Statistical analysis: We have analyzed 10 to 16 cells for each
cell line (about 700 individual force curves per cell line). The
Tukey–Kramer test (P = 0.05) was used to confirm statistical
differences between Young’s modulus of different cell lines.
Fluorescence microscopy: The cells grown on a coverslip were
washed with a RPMI-1640 medium supplemented with 10 mM
HEPES. Next the cells were fixed by adding a 3.7%
paraformaldehyde solution in PBS (phosphate buffered saline,
Sigma) for 10 min and then washed with PBS buffer. The cell
membrane was permeabilized by incubating the cells with a
0.2% Triton X-100 (Sigma) in PBS solution for 5 min. Finally,
cells were rinsed with PBS buffer. Such prepared coverslips
with cells were fluorescently labeled. The actin filaments were
stained with phalloidin fluorescently labeled with Alexa Fluor
488 (Invitrogen) dissolved in PBS buffer (1:200) for 30 min.
Then, the sample was washed with PBS buffer and the cell
nuclei were stained with Hoechst stain (Invitrogen) in PBS
buffer (1:5) for 15 min. The coverslips containing the cells were
washed with PBS buffer, sealed using nail polish, and stored at
4 °C in the dark for 24 to 48 h before image recording.
Force and fluorescence microscopy imaging of the cells: The
AFM is integrated with the inverted optical microscope
equipped with fluorescent functionality. This enables to image
the same region with both techniques and to correlate AFM and
fluorescence data. The fluorescence microscopy was performed
by using an Olympus IX71 inverted microscope (Olympus,
Japan) equipped with a 100 W mercury lamp and U-MWIB2
and U-MWIG2 filters used for actin filaments (Alexa Fluor
488) and cell nuclei (Hoechst stain) visualization, respectively.
For image recording, the Olympus XC10 digital camera (resolu-
tion 1376 × 1032 pixels) was used. Images were recorded using
the program CellSens Dimension (Olympus). The AFM is
equipped with a liquid cell sitting on a x–y piezoscanner with a
range of 100 × 100 µm2. The approach and retraction of the
AFM probe is realized using a separate piezoscanner with a
z-range of 10 μm. The AFM images were obtained in contact
mode by applying a maximum force of 100 pN. The imaging
scan line rate was between 0.5 to 1.0 Hz with a length between
20 to 50 μm. Each image has 512 × 512 pixels.
Western blot method: The Western blot technique is a stan-
dard technique used in cell biology to detect specific proteins in
the sample. It follows through two steps. First, an elec-
trophoresis is performed to separate proteins from a cell extract.
Second, proteins are transferred to a membrane, on which they
are stained using monoclonal antibodies. Each band correspond
to a specific protein with a particular molecular mass.
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